Results 71 to 80 of about 3,475,545 (379)
EMBO Molecular Medicine, 2019 Failures in Alzheimer's disease (AD) drug trials highlight the need to further explore disease mechanisms and alterations of biomarkers during the development of AD.
Sebastian Palmqvist +11 more
doaj +1 more source
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
Alzheimer's Research & Therapy, 2022 Background This study investigated plasma biomarkers for neuroinflammation associated with Alzheimer’s disease (AD) in subjects with preclinical AD compared to healthy elderly.
S. Prins +3 more
semanticscholar +1 more source
Plasma Biomarker of Dietary Phytosterol Intake
PLOS ONE, 2015 Dietary phytosterols, plant sterols structurally similar to cholesterol, reduce intestinal cholesterol absorption and have many other potentially beneficial biological effects in humans. Due to limited information on phytosterol levels in foods, however, it is difficult to quantify habitual dietary phytosterol intake (DPI).
Lin, Xiaobo +5 more
openaire +5 more sources
Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer's disease.
Brain : a journal of neurology, 2022 Hippocampal subfields exhibit differential vulnerabilities to Alzheimer's disease (AD)-associated pathology including abnormal accumulation of beta-amyloid deposition and neurofibrillary tangles.
S. Shahid +10 more
semanticscholar +1 more source
microRNA. Diagnostic Perspective [PDF]
, 2015 Biomarkers are biological measures of a biological state. An ideal marker should be safe and easy to measure, cost efficient, modifiable with treatment, and consistent across gender and ethnic groups. To date, none of the available biomarkers satisfy all
FARUQ, MD OMAR, VECCHIONE, ANDREA
core +2 more sources
Nature Communications, 2021 Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma measurements of amyloid-β (Aβ)42/40, phospho-tau217 (P-tau217), and neurofilament ...
N. Cullen +8 more
semanticscholar +1 more source
, 2013 Purpose of review: This review discusses the current developments in biomarkers for sepsis. Recent findings: With quantum leaps in technology, an array of biomarkers will become available within the next decade as point-of-care tools that will likely ...
Singer, M
core +1 more source
Alzheimer's & DementiaWe compared the ability of several plasma biomarkers versus amyloid positron emission tomography (PET) to predict rates of memory decline among cognitively unimpaired individuals.
C. R. Jack +17 more
semanticscholar +1 more source
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
Alzheimer's & Dementia, 2022 There is a great need for fully automated plasma assays that can measure amyloid beta (Aβ) pathology and predict future Alzheimer's disease (AD) dementia.
S. Palmqvist +18 more
semanticscholar +1 more source
Addressing the needs of traumatic brain injury with clinical proteomics. [PDF]
, 2014 BackgroundNeurotrauma or injuries to the central nervous system (CNS) are a serious public health problem worldwide. Approximately 75% of all traumatic brain injuries (TBIs) are concussions or other mild TBI (mTBI) forms.
Loo, Joseph A +3 more
core +1 more source